Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
409 | 16639 | 45.3 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
409 | 2 | ADENOSINE//ADENOSINE RECEPTORS//ATP | 16639 |
363 | 1 | P2X RECEPTORS//P2Y RECEPTORS//ATP | 3586 |
1134 | 1 | ADENOSINE A2A RECEPTOR//ADENOSINE//A2A RECEPTOR | 2832 |
3075 | 1 | MOL RECOGNIT SECT//ADENOSINE RECEPTORS//ADENOSINE RECEPTOR ANTAGONISTS | 2072 |
3783 | 1 | P2X7 RECEPTOR//P2X7//P2X7R | 1909 |
4306 | 1 | CD73//ADENOSINE RECEPTORS//ADENOSINE | 1808 |
6949 | 1 | NUCLEOSIDE TRANSPORT//NUCLEOSIDE TRANSPORTER//NITROBENZYLTHIOINOSINE | 1425 |
8571 | 1 | NTPDASE//ECTO ATPASE//ATP DIPHOSPHOHYDROLASE | 1239 |
12351 | 1 | KW 3902//ADENOSINE A1 RECEPTOR ANTAGONIST//2 AMP | 912 |
19498 | 1 | ADENOSINE//ADENOSINE KINASE//5 DEOXY 5 IODOTUBERCIDIN | 502 |
25967 | 1 | GUANOSINE//GUANINE BASED PURINES//AIT 082 | 266 |
35980 | 1 | ACUTE LIMBIC SEIZURES//ALLOPUNIROL//BILIMUBIN | 88 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADENOSINE | authKW | 1102674 | 11% | 32% | 1908 |
2 | ADENOSINE RECEPTORS | authKW | 760170 | 5% | 55% | 759 |
3 | ATP | authKW | 469134 | 8% | 20% | 1267 |
4 | P2X7 RECEPTOR | authKW | 397395 | 2% | 72% | 300 |
5 | P2X RECEPTORS | authKW | 396366 | 2% | 69% | 312 |
6 | PURINERGIC SIGNALLING | journal | 356674 | 2% | 67% | 291 |
7 | MOL RECOGNIT SECT | address | 318055 | 1% | 71% | 244 |
8 | ADENOSINE A2A RECEPTOR | authKW | 307507 | 2% | 61% | 273 |
9 | ECTONUCLEOTIDASES | authKW | 306037 | 1% | 73% | 229 |
10 | P2X7 | authKW | 290358 | 1% | 79% | 201 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 33994 | 28% | 1% | 4622 |
2 | Neurosciences | 27961 | 25% | 0% | 4221 |
3 | Physiology | 8740 | 9% | 0% | 1460 |
4 | Chemistry, Medicinal | 7989 | 7% | 0% | 1195 |
5 | Biochemistry & Molecular Biology | 6213 | 20% | 0% | 3305 |
6 | Cell Biology | 2740 | 9% | 0% | 1425 |
7 | Biophysics | 1285 | 4% | 0% | 717 |
8 | Immunology | 614 | 5% | 0% | 811 |
9 | Peripheral Vascular Diseases | 605 | 3% | 0% | 425 |
10 | Medicine, Research & Experimental | 536 | 3% | 0% | 558 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL RECOGNIT SECT | 318055 | 1% | 71% | 244 |
2 | AUTON NEUROSCI | 162993 | 1% | 49% | 180 |
3 | RUDOLF BOEHM PHARMACOL TOXICOL | 77895 | 1% | 40% | 106 |
4 | AUTONOM NEUROSCI | 68216 | 0% | 50% | 74 |
5 | PHARMA BONN | 50996 | 0% | 45% | 62 |
6 | SECT MOL NEUROPHARMACOL | 47329 | 0% | 70% | 37 |
7 | NEW ENGLAND INFLAMMAT TISSUE PROTECT | 39905 | 0% | 66% | 33 |
8 | MUCOSAL INFLAMMAT PROGRAM | 35635 | 0% | 35% | 56 |
9 | NEUROSCI COIMBRA | 28255 | 0% | 33% | 47 |
10 | AK NEUROCHEM | 28143 | 0% | 59% | 26 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PURINERGIC SIGNALLING | 356674 | 2% | 67% | 291 |
2 | BRITISH JOURNAL OF PHARMACOLOGY | 43407 | 4% | 4% | 654 |
3 | DRUG DEVELOPMENT RESEARCH | 34896 | 1% | 8% | 238 |
4 | EUROPEAN JOURNAL OF PHARMACOLOGY | 18033 | 3% | 2% | 537 |
5 | MOLECULAR PHARMACOLOGY | 12377 | 2% | 3% | 261 |
6 | JOURNAL OF NEUROCHEMISTRY | 11917 | 2% | 2% | 377 |
7 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 11651 | 2% | 2% | 375 |
8 | JOURNAL OF MEDICINAL CHEMISTRY | 9437 | 2% | 2% | 342 |
9 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 9397 | 1% | 3% | 179 |
10 | NEUROPHARMACOLOGY | 7493 | 1% | 2% | 200 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOSINE | 1102674 | 11% | 32% | 1908 | Search ADENOSINE | Search ADENOSINE |
2 | ADENOSINE RECEPTORS | 760170 | 5% | 55% | 759 | Search ADENOSINE+RECEPTORS | Search ADENOSINE+RECEPTORS |
3 | ATP | 469134 | 8% | 20% | 1267 | Search ATP | Search ATP |
4 | P2X7 RECEPTOR | 397395 | 2% | 72% | 300 | Search P2X7+RECEPTOR | Search P2X7+RECEPTOR |
5 | P2X RECEPTORS | 396366 | 2% | 69% | 312 | Search P2X+RECEPTORS | Search P2X+RECEPTORS |
6 | ADENOSINE A2A RECEPTOR | 307507 | 2% | 61% | 273 | Search ADENOSINE+A2A+RECEPTOR | Search ADENOSINE+A2A+RECEPTOR |
7 | ECTONUCLEOTIDASES | 306037 | 1% | 73% | 229 | Search ECTONUCLEOTIDASES | Search ECTONUCLEOTIDASES |
8 | P2X7 | 290358 | 1% | 79% | 201 | Search P2X7 | Search P2X7 |
9 | P2 RECEPTORS | 283236 | 2% | 61% | 253 | Search P2+RECEPTORS | Search P2+RECEPTORS |
10 | P2Y RECEPTORS | 245545 | 1% | 60% | 223 | Search P2Y+RECEPTORS | Search P2Y+RECEPTORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RALEVIC, V , BURNSTOCK, G , (1998) RECEPTORS FOR PURINES AND PYRIMIDINES.PHARMACOLOGICAL REVIEWS. VOL. 50. ISSUE 3. P. 413 -492 | 743 | 78% | 2841 |
2 | BURNSTOCK, G , (2007) PHYSIOLOGY AND PATHOPHYSIOLOGY OF PURINERGIC NEUROTRANSMISSION.PHYSIOLOGICAL REVIEWS. VOL. 87. ISSUE 2. P. 659 -797 | 910 | 53% | 748 |
3 | BURNSTOCK, G , KNIGHT, GE , (2004) CELLULAR DISTRIBUTION AND FUNCTIONS OF P2 RECEPTOR SUBTYPES IN DIFFERENT SYSTEMS.INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL. 240. VOL. 240. ISSUE . P. 31 -+ | 1226 | 52% | 382 |
4 | NORTH, RA , (2002) MOLECULAR PHYSIOLOGY OF P2X RECEPTORS.PHYSIOLOGICAL REVIEWS. VOL. 82. ISSUE 4. P. 1013-1067 | 404 | 80% | 1767 |
5 | KACZMAREK-HAJEK, K , LORINCZI, E , HAUSMANN, R , NICKE, A , (2012) MOLECULAR AND FUNCTIONAL PROPERTIES OF P2X RECEPTORS-RECENT PROGRESS AND PERSISTING CHALLENGES.PURINERGIC SIGNALLING. VOL. 8. ISSUE 3. P. 375 -417 | 490 | 87% | 64 |
6 | CODDOU, C , YAN, ZH , OBSIL, T , HUIDOBRO-TORO, JP , STOJILKOVIC, SS , (2011) ACTIVATION AND REGULATION OF PURINERGIC P2X RECEPTOR CHANNELS.PHARMACOLOGICAL REVIEWS. VOL. 63. ISSUE 3. P. 641 -683 | 428 | 81% | 173 |
7 | BURNSTOCK, G , RALEVIC, V , (2014) PURINERGIC SIGNALING AND BLOOD VESSELS IN HEALTH AND DISEASE.PHARMACOLOGICAL REVIEWS. VOL. 66. ISSUE 1. P. 102 -192 | 686 | 46% | 68 |
8 | BOURS, MJL , SWENNEN, ELR , DI VIRGILIO, F , CRONSTEIN, BN , DAGNELIE, PC , (2006) ADENOSINE 5 '-TRIPHOSPHATE AND ADENOSINE AS ENDOGENOUS SIGNALING MOLECULES IN IMMUNITY AND INFLAMMATION.PHARMACOLOGY & THERAPEUTICS. VOL. 112. ISSUE 2. P. 358 -404 | 466 | 69% | 458 |
9 | BURNSTOCK, G , BOEYNAEMS, JM , (2014) PURINERGIC SIGNALLING AND IMMUNE CELLS.PURINERGIC SIGNALLING. VOL. 10. ISSUE 4. P. 529 -564 | 410 | 75% | 26 |
10 | BURNSTOCK, G , KRUGEL, U , ABBRACCHIO, MP , ILLES, P , (2011) PURINERGIC SIGNALLING: FROM NORMAL BEHAVIOUR TO PATHOLOGICAL BRAIN FUNCTION.PROGRESS IN NEUROBIOLOGY. VOL. 95. ISSUE 2. P. 229 -274 | 432 | 63% | 144 |
Classes with closest relation at Level 2 |